Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 4
Submit an article Journal homepage
247
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Circulating endothelial progenitor cells as potential prognostic biomarker in multiple myeloma

Archana BhaskarLaboratory Oncology Unit
,
Ritu GuptaLaboratory Oncology UnitCorrespondence[email protected] [email protected]
,
Lalit KumarDepartment of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
,
Atul SharmaDepartment of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, India
,
Mehar Chand SharmaDepartment of Pathology
,
Mani KalaivaniDepartment of Biostatistics, All India Institute of Medical Sciences, New Delhi, India
&
Sonu Chand ThakurCenter for Interdisciplinary Research in Basic Sciences, Jamia Millia University, New Delhi, India
 show all
Pages 635-640 | Received 13 Sep 2011, Accepted 23 Sep 2011, Published online: 27 Apr 2012

References

  • Vacca A, Ribatti D, Roncali L, . Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994;87:503–508.
  • Rajkumar SV, Mesa RA, Fonseca R, . Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Clin Cancer Res 2002;8:2210–2216.
  • Anderson KC. Moving disease biology from the lab to the clinic. Cancer 2003;97:796–801.
  • Sato Y. Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy. Int J Clin Oncol;2003;8:200–206.
  • Kropff M, Bisping G, Wenning D, . Proteasome inhibition in multiple myeloma. Eur J Cancer 2006;42:1623–1639.
  • Laubach JP, Mahindra A, Mitsiades CS, . The use of novel agents in the treatment of relapsed and refractory multiple myeloma. Leukemia 2009;23:2222–2232.
  • Quach H, Ritchie D, Stewart AK, . Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma. Leukemia 2010;24:22–32.
  • Mancuso P, Burlini A, Pruneri G, . Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 2001;97:3658–3661.
  • Beerepoot LV, Mehra N, Vermaat JS, . Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol 2004;15:139–145.
  • Naik RP, Jin D, Chuang E, . Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer. Breast Cancer Res Treat 2008;107:133–138.
  • Nowak K, Rafat N, Belle S, . Circulating endothelial progenitor cells are increased in human lung cancer and correlate with stage of disease. Eur J Cardiothorac Surg 2010;37:758–763.
  • Peichev M, Naiyer AJ, Pereira D, . Expression of VEGFR-2 and AC133 by circulating human CD34 (+) cells identifies a population of functional endothelial precursors. Blood 2000;95:952–958.
  • Mauro E, Rigolin GM, Fraulini C, . Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation. Eur J Hematol 2007;8:374–380.
  • Duda DG, Cohen KS, Scadden DT, . A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2007;2:805–810.
  • Case J, Mead LE, Bessler WK, . Human CD34 +AC133+VEGFR-2+cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007; 35: 1109–1118.
  • Yoder MC, Mead LE, Prater DL, . Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem progenitor cell principals. Blood 2007;109:1801–1809.
  • Durie BGM, Harousseau JL, Miguel JS, . International uniform response criteria for multiple myeloma. Leukemia 2006;20: 1467–1473.
  • Greipp PR, San Miguel J, Durie BG, . International staging system for multiple myeloma. J Clin Oncol 2005;23:3412–3420.
  • Zhang H, Vakil V, Braunstein M, . Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood 2005;105:3286–3294.
  • Bhatti SS, Kumar L, Dinda AK, . Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological and laboratory parameters. Am J Hematol 2006; 81:649–656.
  • Rajkumar SV, Leong T, Roche PC, . Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res 2000; 6:3111–3116.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.